Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9ISI

Structure of human C3aR in apo state

Summary for 9ISI
Entry DOI10.2210/pdb9isi/pdb
EMDB information60836
DescriptorC3a anaphylatoxin chemotactic receptor,Soluble cytochrome b562 (1 entity in total)
Functional Keywordsgpcr, membrane protein
Biological sourceHomo sapiens (human)
More
Total number of polymer chains1
Total formula weight68608.29
Authors
Kim, J.,Ko, S.,Choi, H.-J. (deposition date: 2024-07-17, release date: 2025-04-23, Last modification date: 2025-07-16)
Primary citationKim, J.,Ko, S.,Choi, C.,Bae, J.,Byeon, H.,Seok, C.,Choi, H.J.
Structural insights into small-molecule agonist recognition and activation of complement receptor C3aR.
Embo J., 44:2803-2826, 2025
Cited by
PubMed Abstract: The complement system plays crucial roles in innate immunity and inflammatory responses. The anaphylatoxin C3a mediates pro-inflammatory and chemotactic functions through the G protein-coupled receptor C3aR. While the active structure of the C3a-C3aR-G complex has been determined, the inactive conformation and activation mechanism of C3aR remain elusive. Here we report the cryo-EM structure of ligand-free, G protein-free C3aR, providing insights into its inactive conformation. In addition, we determine the structures of C3aR in complex with the synthetic small-molecule agonist JR14a in two distinct conformational states: a G protein-free intermediate, and a fully active G-bound state. The structure of the active JR14a-bound C3aR reveals that JR14a engages in highly conserved interactions with C3aR, similar to the binding of the C-terminal pentapeptide of C3a, along with JR14a-specific interactions. Structural comparison of C3aR in the apo, intermediate, and fully active states provides novel insights into the conformational landscape and activation mechanism of C3aR and defines a molecular basis explaining its high basal activity. Our results may aid in the rational design of therapeutics targeting complement-related inflammatory disorders.
PubMed: 40195498
DOI: 10.1038/s44318-025-00429-w
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.56 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon